Cervical Lymphadenopathy in Concomitant CML and Tuberculosis: A Case Report.

IF 0.7 Q4 ONCOLOGY
Case Reports in Oncology Pub Date : 2025-05-20 eCollection Date: 2025-01-01 DOI:10.1159/000546368
Afia Aziz, Awni Alshurafa, Mohammad Yassin
{"title":"Cervical Lymphadenopathy in Concomitant CML and Tuberculosis: A Case Report.","authors":"Afia Aziz, Awni Alshurafa, Mohammad Yassin","doi":"10.1159/000546368","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic myeloid leukemia is a myeloproliferative disorder characterized by the uncontrolled proliferation of mature and maturing granulocytes in the bone marrow, along with the presence of the Philadelphia chromosome. Lymphadenopathy is an uncommon initial manifestation of CML and is typically attributed to the disease itself. However, with the use of tyrosine kinase inhibitors (TKIs), which can affect T-cell-mediated immunity, new or persistent lymphadenopathy in CML patients warrants investigation to rule out opportunistic infections, including tuberculosis (TB), or progression to the blast phase of CML.</p><p><strong>Case presentation: </strong>A 35-year-old male diagnosed with chronic-phase CML initially presented with cervical lymphadenopathy. The lymphadenopathy was initially attributed to CML. Further evaluation, including a lymph node biopsy, revealed concurrent TB infection. Treatment with appropriate anti-tuberculous therapy led to the resolution of the lymphadenopathy.</p><p><strong>Conclusion: </strong>This case highlights the importance of considering opportunistic infections, such as TB, in CML patients presenting with lymphadenopathy, particularly those on TKI therapy. Prompt investigation and appropriate management are crucial to avoid complications and ensure optimal patient outcomes.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"18 1","pages":"751-755"},"PeriodicalIF":0.7000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173442/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000546368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chronic myeloid leukemia is a myeloproliferative disorder characterized by the uncontrolled proliferation of mature and maturing granulocytes in the bone marrow, along with the presence of the Philadelphia chromosome. Lymphadenopathy is an uncommon initial manifestation of CML and is typically attributed to the disease itself. However, with the use of tyrosine kinase inhibitors (TKIs), which can affect T-cell-mediated immunity, new or persistent lymphadenopathy in CML patients warrants investigation to rule out opportunistic infections, including tuberculosis (TB), or progression to the blast phase of CML.

Case presentation: A 35-year-old male diagnosed with chronic-phase CML initially presented with cervical lymphadenopathy. The lymphadenopathy was initially attributed to CML. Further evaluation, including a lymph node biopsy, revealed concurrent TB infection. Treatment with appropriate anti-tuberculous therapy led to the resolution of the lymphadenopathy.

Conclusion: This case highlights the importance of considering opportunistic infections, such as TB, in CML patients presenting with lymphadenopathy, particularly those on TKI therapy. Prompt investigation and appropriate management are crucial to avoid complications and ensure optimal patient outcomes.

宫颈淋巴结病并发CML和结核1例报告。
慢性髓性白血病是一种骨髓增殖性疾病,其特征是骨髓中成熟和成熟粒细胞不受控制的增殖,并伴有费城染色体的存在。淋巴结病变是CML的一种罕见的初始表现,通常归因于疾病本身。然而,随着酪氨酸激酶抑制剂(TKIs)的使用,可以影响t细胞介导的免疫,CML患者的新发或持续性淋巴结病变需要进行调查,以排除机会性感染,包括结核病(TB),或CML进展到原细胞期。病例介绍:一名35岁男性,诊断为慢性慢性粒细胞白血病,最初表现为宫颈淋巴结病。淋巴结病变最初归因于CML。进一步的评估,包括淋巴结活检,发现并发结核感染。经适当的抗结核治疗,淋巴结病变得以缓解。结论:本病例强调了考虑机会性感染的重要性,如结核,在CML患者出现淋巴结病变,特别是那些在TKI治疗。及时的调查和适当的管理是避免并发症和确保最佳的患者结果的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
12.50%
发文量
151
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信